Elevance Health
ELVElevance Health is a leading health company focused on delivering integrated, whole-health solutions across the care journey.
Earnings
Next report
Jul 16, 2026 (In 6 days)Valuation & ratios
Segments
By product
Competitors
By market cap
By revenue growth
Profile
Elevance Health is a leading health company focused on delivering integrated, whole-health solutions across the care journey. The company provides a comprehensive suite of medical, pharmacy, behavioral, and specialty health services to millions of members through its affiliated health plans and healthcare services brands. Its core value proposition centers on leveraging local market presence and national scale to improve health outcomes and advance health equity through value-based care models.
One of the largest health insurers in the United States by medical membership, holding exclusive Blue Cross Blue Shield licenses in 14 states.
Questions, answered.
- What is Elevance Health's market cap?
- Elevance Health (ELV) has a market capitalization of $90.4B and trades on NYSE.
- What is Elevance Health's revenue and profitability?
- Elevance Health generated $200.42B in trailing twelve-month revenue with net income of $5.2B, representing a net margin of 2.6%. Gross margin stands at 89.2%, with free cash flow of $6.7B. These figures are based on the Q1 2026 filing.
- Who are Elevance Health's competitors?
- Elevance Health's key competitors include Humana Inc., Aetna (CVS Health), UnitedHealth Group Incorporated, and others. These companies compete in similar markets and product categories.
- Who does Elevance Health partner with?
- Elevance Health's notable partners include Blue Cross and Blue Shield Association, CVS Health Corporation, Clayton, Dubilier & Rice, and others.
- What subsidiaries does Elevance Health have?
- Elevance Health's subsidiaries include Carelon, CarelonRx, Wellpoint, and others.
- Where is Elevance Health headquartered?
- Elevance Health is headquartered in United States of America and employs approximately 104,900 people. It has been publicly traded since 2001.